TAG:
lab test cost
Lab Serving Large MD Group Manages Quality and Costs
By Joseph Burns | From the Volume XXI NO. 6 – April 28, 2014 Issue
CEO SUMMARY: For decades, pathologists have pointed out that their expertise in laboratory medicine can be tapped by physicians to improve utilization of lab tests, contribute to improved patient outcomes, and reduce the overall cost of care. Exactly that is now happening at Atrius Heal…
Physician Group ACO Targets High-Volume Tests for Savings
By Joseph Burns | From the Volume XXI No. 3 – February 24, 2014 Issue
HERE’S AN EXAMPLE OF HOW an accountable care organization views cost control. Atrius Health sought to control excess costs by focusing on high-priced items. It started with inappropriate hospitalizations and imaging studies and moved on to laboratory testing. Atrius Health is…
Broward Health’s Lab Pursues Multiple Ways to Cut Lab Costs
By Joseph Burns | From the Volume XX No. 15 – November 11, 2013 Issue
CEO SUMMARY: Tasked with cutting $2 million from their lab’s annual operating budget, the lab team at Broward Health System instituted changes that included a lab test formulary and ordering algorithms. In collaboration with physicians, these changes reduced the use of outmoded tests wh…
Aetna To Lower Lab Test Prices, New Fees Are Effective on July 1
By Robert Michel | From the Volume XX No. 7 – May 28, 2013 Issue
IN RECENT MONTHS, labs are reporting the receipt of letters from Aetna, Inc., announcing that it will pay dramatically less than Medicare prices for many key lab tests. Aetna said that these lower prices will take effect on July 1, 2013. Three examples illustrate the deep fee cuts t…
Health Insurers Now Finding Ways to Cut Costs and Shed Risks
By Robert Michel | From the Volume XIX No. 8 – June 4, 2012 Issue
CEO SUMMARY: Both employers and health insurers are taking aggressive steps to rein in healthcare costs. Several strategies to control spending and create powerful new incentives for providers are gaining favor. At this year’s Executive War College, Paul Mango of McKinsey & Company,…
Medicare Carrier Plans to Reject Molecular Claims
By Robert Michel | From the Volume XVIII No. 15 – November 7, 2011 Issue
CEO SUMMARY: In September, Palmetto, a Medicare carrier serving California and seven other states, made public two draft local coverage determinations (LCDs) that revamp its coverage guidelines for molecular diagnostic tests (MDT) and laboratory-developed tests (LDT). All labs su…
How Could So Many Labs Violate California Law?
By Robert Michel | From the Volume XVII No. 18 – December 27, 2010 Issue
CEO SUMMARY: If a 40-year-old state law on Medi-Cal pricing was known to regulators and clinical laboratories alike, how did the legal and compliance departments of so many laboratories—staffed by some of the smartest legal minds in California and nationally—interpret the law…
HealthPartners Promotes Same-Day Lab Test Results
By Robert Michel | From the Volume XV No. 9 – July 7, 2008 Issue
CEO SUMMARY: Patient focus groups told HealthPartners that they had anxiety as they waited days for lab test results. That encouraged HealthPartners to redesign workflows in its pathology department. Once it could deliver same-day lab test results electronically, HealthPartners launched a…
Community Hospital Builds Thriving Lab Outreach Program
By Robert Michel | From the Volume XIV No. 8 – June 4, 2007 Issue
CEO SUMMARY: When 330-bed Botsford Hospital of Farmington Hills, Michigan, got interested in laboratory outreach 10 years ago, it brought in a new laboratory leader, invested in new analyzers and informatics, and then let the quality of the operation attract new business from the communit…
FL Medicaid Gives Up On Statewide Lab Contract
By Robert Michel | From the Volume XII No. 4 – March 7, 2005 Issue
CEO SUMMARY: With the withdrawal of the December 13, 2004 “Invitation to Negotiate” (ITN), Florida’s Medicaid bureaucrats seem to have thrown in the towel—at least for the moment—on the effort to give a single laboratory company an exclusive three-year contract to provide labora…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized